This interactive webinar provides the opportunity for those shaping, impacted by or influencing the future of new drug discovery and development in the UK to share thoughts on the current situation, what they feel the future holds and what support they feel would be useful from Government or others to support any transition.  
 
Recent years has seen a decided shift in investor and biotech company focus driven primarily by the prolonged challenging financing dynamics for the sector, emergence of TechBio in drug discovery and geographic changes on the sourcing of early-stage bio-innovation. 
 
The significant impact on the employment of those skilled in R&D disciplines have bene profound, most notably the focus of investors on later stage assets and consequently the priorities of biotech leadership teams moving to clinical development away from resourcing discovery labs. This has manifested in high rates of R&D staff redundancies and higher than expected lab vacancy rates.
 
*Agenda:
16.00 – Welcome for One Nucleus, Tony Jones, One Nucleus 
16.05 – Current Landscape and Impact on R&D Employment, Natasha Robbins, BioTc Search
16.10 – Encouraging Biotechs to Scale in the UK, David Montgomery, PM Life Sciences Consultancy
16.15 – Panel Q&A - Actions Required to Support Biotech Future
Moderator – Tony Jones, One Nucleus
Panellists -  Matthew Fyfe, Outrun Therapeutics; Sheuli Porkess, PM Life Sciences Consultancy; Dave Graham, The UK Innovation Corridor; Natasha Robbins, BioTc Search; David Montgomery, PM Life Sciences Consultancy
16.55 – Closing Remarks and Next Steps
17.00 – Close

*Subject to change.
 
Registration:
Free for all to attend but pre-registration essential.